pharmaceuticals-and-healthcare

China Influenza Vaccine Industry 2014 Deep Research Report


Published On : Jan 2014

Category : Vaccines

No. of Pages : 201 pages

  • $2200
  • $4500

Please click below to avail discount on this report


Firstly the report describes the background knowledge of Influenza Vaccine, including Concepts Classification Manufacturing process technical parameters and equipments List etc; then statistics International and China 16 Manufacturers Influenza Vaccine product 2009-2017 Capacity production cost price production value profit margins and other relevant data, statistics these enterprises Influenza Vaccine products, Product Specifications, company background information, then summary statistics and analysis the relevant data on these enterprises. The report got Global and China Influenza Vaccine companies production market share, China Influenza Vaccine demand supply and shortage,  China Influenza Vaccine 2009-2017 production price cost profit production value profit margins, production market share by different Sources(China Domestic and Imported etc) . 

At the same time, the report analyzed and discussed supply and demand changes in Influenza Vaccine market and business development strategies, conduct a comprehensive analysis on China Influenza Vaccine industry trends. Finally, the report also introduced 8Million Pieces/year Influenza Vaccine project Feasibility analysis and related research conclusions. In a word, It was a depth research report on China Influenza Vaccine industry. And thanks to the support and assistance from Influenza Vaccine industry chain related experts and enterprises during Research Team survey and interview.
Tables and Figures

Table Common Vaccines Classification 2
Table United States Approval Type A influenza H1N1 Vaccine Suppliers and Product Specifications List 5
Table Europe Approval Type A influenza H1N1 Vaccine Suppliers and Product Specifications List 7
Table China First Type Vaccine and Second Type Vaccine Classification and Application 11
Table First Type Vaccine and Second Type Vaccine Detail Market Analysis 12
Table 2009-2013 China First Type Vaccine and Second Type Vaccine Issue Number (10K Pieces) and Market Share 14
Figure 2013 State-owned Private Foreign Enterprise Market Share in First Type Vaccine and Second Type Vaccine 14
Figure Influenza Vaccine Industry Chain Structure 15
Figure Vaccine Cold Chain Circulation System 16
Figure Vaccine Transportation Model 16
Figure First Type Vaccine Transportation Channel 17
Figure Second Type Vaccine Transportation Channel 18
Figure Vaccine Transportation Steps and Process 18
Figure 2009-2019 Global Influenza Vaccine Market Scale(100 Million USD) 20
Figure 2013 United States TOP5 Suppliers Influenza Vaccine Market Share 21
Figure China Influenza Vaccine Inoculation Coverage Rate and Its Gap to International Goal 23
Table Baxter Vero Cell Platform Background Information 28
Figure Embryo Culture Inactivated Vaccine Manufacturing Process Flow 30
Figure Cell Culture Inactivated Influenza Vaccine Manufacturing Process Flow 32
Figure Two Influenza Vaccine Manufacturing Process Comparison 33
Figure Influenza Vaccine Manufacturing Steps 36
Figure Influenza Vaccine Detection Steps 37
Table Influenza Vaccine Manufacturing Equipments List (38 Equipments) 37
Figure Influenza Vaccine Production Periodic Table 40
Figure Influenza Vaccine Production schedules 41
Table Influenza Vaccine Development History 42
Table Existing and R&D Influenza Vaccine Products List 42
Figure Influenza Vaccine New Manufacturing Technology 45
Table China 11 Manufacturers Influenza Vaccine Market Status List 47
Table Selling Influenza Vaccine in China 5 Foreign Suppliers List 48
Table 2009-2017 China 11 Manufacturers Influenza Vaccine Capacity and Total Capacity (10K Pieces) List 49
Table 2009-2017 China 11 Manufacturers Influenza Vaccine Capacity Market Share List 49
Table 2009-2017 China 11 Manufacturers Influenza Vaccine Production and Total Production (10K Pieces) List 50
Table 2009-2017 China 11 Manufacturers Influenza Vaccine Production Market Share List 50
Table 2009-2017 China Influenza Vaccine Capacity Production (10K Pieces) and Capacity Utilization Rate 51
Figure 2009-2017 China Influenza Vaccine Capacity Production (10K Pieces) and Growth Rate 52
Figure 2013 China Key Manufacturers Influenza Vaccine Production Market Share (China Government Approcal Data) 52
Table 2009-2017 Global Key Suppliers Influenza Vaccine Capacity and Total Capacity (100 Million Pieces) List 53
Table 2009-2017 Global Key Suppliers Influenza Vaccine Production and Total Production (100 Million Pieces) List 53
Figure 2009-2017 Global Influenza Vaccine Capacity Production (100 Million Pieces) and Growth Rate 54
Table 2009-2017 Global Influenza Vaccine Capacity Production (100 Million Pieces) and Capacity Utilization Rate 54
Figure 2011 Global Key Suppliers Influenza Vaccine Production Market Share 55
Table 2009-2017 Global Key Suppliers Influenza Vaccine China Sales (10K Pieces) List 55
Figure 2013 China Imported Influenza Vaccine Market Share By Suppliers (China Government Approval Data) 56
Table Global and China Key Suppliers Key Vaccine Products Sales in China 56
Table 2007-2011 China Influenza Vaccine Approval Amount by Suppliers (10K Pieces) 57
Figure 2013 China Influenza Vaccine Market Share by Splitting Vaccine and Subunit Vaccine (according China government approval amount) 59
Table 2009-2017 China local Influenza Vaccine and Imported Influenza Vaccine Market Share Comparison 59
Table 2001-2020 China Birth Rate and Population (10K) 60
Figure China India Korea Japan etc 9 Countries Child Mortality (‰) 61
Figure 1950-2050 China Working-age Population Proportion (%) 61
Table 2000-2050 China Age Over 60 Population (100 Million) and Proportion (%) 61
Figure 2010-2050 China Age Over 60 Over 65 Over 80 Population Proportion 62
Table 2001-2015 China Per Capita GDP (USD) and Growth Rate 63
Figure 2009-2017 China Influenza Vaccine Supply Demand (10K Pieces) and Growth Rate 63
Figure China Japan France etc 9 Countries Age Over 65 Population Influenza Vaccine Inoculation Coverage Rate 64
Table 2009-2017 China Influenza Vaccine Supply Demand and Shortage (10K Pieces) 64
Table 2013 Hangzhou Disease Control and Prevention Center 33 Type Influenza Vaccine Products Purchase and Selling Price (RMB/Piece) 65
Table 2013 China and Imported Influenza Vaccine Capacity Production (10K Pieces) Price Cost Profit (RMB/Piece) Gross Margin List 71
Table 2009-2017 China Influenza Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 71
Table Hualan Bio Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 72
Figure Hualan Bio Vaccine Factory Picture 74
Figure Hualan Bio Influenza Virus Split Vaccine (Childhood Type) 77
Figure Hualan Bio Influenza Virus Split Vaccine (Adult Type) 82
Figure Hualan Bio Type A H1N1 Influenza Virus Split Vaccine 82
Table 2009-2017 Hualan Bio Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 84
Figure 2009-2017 Hualan Bio Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 84
Table Sinovac Biotech Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 85
Table Sinovac Biotech Vaccine Plant Picture 87
Table Sinovac Biotech Development History Time Table 90
Figure Sinovac Biotech Influenza Virus Split Vaccine-Anrlaifu 91
Figure Sinovac Biotech Pandemic Influenza Virus Inactivated Vaccine - Panrlaifu 94
Figure Sinovac Biotech Type A H1N1 Influenza Virus Split Vaccine - Panrlaifu.1 98
Table 2009-2017 Sinovac Biotech Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 102
Figure 2009-2017 Sinovac Biotech Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 103
Table Tianyuan Bio-pharma Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 104
Figure Tianyuan Bio-pharma Influenza Vaccine Products List 107
Figure Tianyuan Bio-pharma Influenza Virus Split Vaccine - Yuganning 108
Table 2009-2017 Tianyuan Bio-pharma Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 110
Figure 2009-2017 Tianyuan Bio-pharma Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 111
Table Changsheng Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 112
Figure Changsheng Influenza Virus Split Vaccine - Wanxin 114
Figure Changsheng Type A H1N1 Influenza Virus Split Vaccine 118
Table 2009-2017 Changsheng Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 118
Figure 2009-2017 Changsheng Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 119
Table Aleph Biomedical Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 119
Table Aleph Biomedical Contact Information List 122
Figure Aleph Biomedical Influenza Vaccine Manufacturing Workshop 123
Figure Aleph Biomedical Influenza Virus Split Vaccine(Adult Type) 123
Figure Aleph Biomedical Influenza Virus Split Vaccine (Childhood Type) 125
Table 2009-2017 Aleph Biomedical Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 127
Figure 2009-2017 Aleph Biomedical Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 128
Table SIOBP (Shanghai Institute of Biological Products) Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 129
Figure CNBG and Six Institutes Equity Relationship 133
Figure SIOBP Influenza Virus Split Vaccine 135
Figure SIOBP Type A H1N1 Influenza Virus Split Vaccine 135
Table 2009-2017 SIOBP Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 136
Figure 2009-2017 SIOBP Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 137
Table CCBIO(Changchun Institute of Biological Products) Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 137
Figure CCBIO Influenza Split Vaccine - Shipulir 139
Figure CCBIO Factory Workshop Picture 139
Table 2009-2017 CCBIO Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 140
Figure 2009-2017 CCBIO Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 141
Table Lanzhou Institute of Biological Products Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 141
Figure Lanzhou Institute of Biological Products Factory Picture 143
Table Lanzhou Institute of Biological Products Trivalent Influenza Split Vaccine 144
Table 2009-2017 Lanzhou Institute of Biological Products Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 148
Figure 2009-2017 Lanzhou Institute of Biological Products Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 149
Table Tiantan Biological Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 150
Figure Tiantan Biological Control Shares of Sinopharm 152
Figure Tiantan Biological and Related Control Subsidiaries Relationship 152
Figure Tiantan Biological Factory Picture 153
Figure Tiantan Biological Beijing Yizhuang Vaccine Plants Picture 153
Figure Tiantan Biological Type A H1N1 Influenza Virus Split Vaccine 154
Figure Tiantan Biological Influenza Virus Split Vaccine 154
Table 2009-2017 Tiantan Biological Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 154
Figure 2009-2017 Tiantan Biological Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 155
Table Sanofi-pasteur Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 156
Figure Sanofi-pasteur China Pharmaceutical Factories Distribution 158
Figure Influenza Virus Split Vaccine-Fanrling 158
Table 2009-2017 Sanofi-pasteur Influenza Virus Split Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 159
Figure 2009-2017 Sanofi-pasteur Influenza Virus Split Vaccine Capacity Production (100Million Pieces) and Growth Rate 159
Table GSK Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 160
Figure GSK Shenzhen Influenza Vaccine Workshop Pictures 164
Figure GSK Influenza Split Vaccine - Fluarix 165
Table 2009-2017 GSKInfluenza Virus Split Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 165
Figure 2009-2017 GSKInfluenza Virus Split Vaccine Capacity Production (100Million Pieces) and Growth Rate 166
Table Novartis Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 167
Figure Novartis Subunit Influenza Vaccine - Agrippal 169
Figure Novartis Aged Population Special Use Influenza Vaccine - Fluad 169
Table 2009-2017 Novartis Influenza Virus Subunit Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 169
Figure 2009-2017 Novartis Influenza Virus Subunit Vaccine Capacity Production (100Million Pieces) and Growth Rate 170
Table Abbott Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 170
Figure Abbott Influenza Subunit Vaccine - Influvac 172
Table 2009-2017 Abbott Subunit Influenza Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 173
Figure 2009-2017 Abbott Subunit Influenza Vaccine Capacity Production (100Million Pieces) and Growth Rate 173
Table Crucell Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 174
Table Crucell Selling Vaccines and R&D Projects List 176
Table Crucell V Type Virion Adjuvant Influenza Vaccine (Subunit ) - Inflexal 176
Table 2009-2017 Crucell Subunit Influenza Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 177
Table 2009-2017 Crucell Subunit Influenza Vaccine Capacity Production (100Million Pieces) and Growth Rate 177
Table Tasly&Jenner Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 178
Figure Tasly&Jenner Factory Pictures 179
Figure Tasly&Jenner Subunit Influenza Virus Split Vaccine-Fuluoke® 180
Table 2009-2017 Tasly&Jenner  Influenza Virus Subunit Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 180
Table 2009-2017 Tasly&Jenner Influenza Virus Subunit Vaccine Capacity Production (10K Pieces) and Growth Rate 181
Table Neptunus Interlong Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 182
Figure Neptunus Interlong Vaccine Factory Picture 183
Figure Neptunus Interlong Vaccine Workshop Picture 184
Figure Neptunus Interlong Influenza Subunit Vaccine Package 184
Table 2009-2017 Neptunus Interlong Influenza Virus Subunit Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 184
Table 2009-2017 Neptunus Interlong Influenza Virus Subunit Vaccine Capacity Production (10K Pieces) and Growth Rate 185
Table China 8Million Pieces/Year Influenza Vaccine Project Investments List 188
Table China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis 189

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top